1 / 26

Pancreas Cyst

Pancreas Cyst. Eric Trawick EUS Conference June 2011. Overview. Pancreatic cysts are being diagnosed with increasing frequency due to the widespread use of cross-sectional imaging Estimated prevalence of 1% in the general population Up to 40% are asymptomatic

nodin
Download Presentation

Pancreas Cyst

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pancreas Cyst Eric Trawick EUS Conference June 2011

  2. Overview • Pancreatic cysts are being diagnosed with increasing frequency due to the widespread use of cross-sectional imaging • Estimated prevalence of 1% in the general population • Up to 40% are asymptomatic • Pancreatic cysts can be divided into 2 broad categories • Neoplastic • Classified by the type of epithelium lining the cyst • Non-neoplastic • Pseudocyst • Non-neoplastic pancreatic cysts (rare) • Include retention cyst & True cysts • Retention cysts • Mucinous non-neoplastic cysts • Lymphoepithelial cysts • Accurate cyst categorization is needed for proper management JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  3. Overview • Rarely, solid pancreatic tumors may present as pancreatic cyst • Islet cell tumor • Pancreatic cystic lesions are usually an isolated finding, but are associated with both von Hippel-Lindau disease and ADPKD • Pancreatic cyst are present in up to 70% of patients with von Hippel-Lindau disease • Approximately 10% of patients with ADPKD have pancreatic cyst JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  4. Cross-sectional Imaging • Unreliable means of diagnosis when used alone • Up to 40% of serous and mucinous lesions are misdiagnosed as pseudocysts • Diagnostic accuracy of CT is reported between 20- 83% • MRI is equivalent or slightly better than CT for diagnosis of cystic pancreatic lesions • As expected MRCP is superior to CT in defining ductal anatomy JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  5. Journal of Computer Assisted Tomography. 1999 23(6):906-912.

  6. Indication for EUS • No hard and fast rules • Will EUS change management? • Symptomatic or worrisome lesions are usually resected without need for EUS &/or FNA • Is there a clear history of pancreatitis and a new cystic lesion? • If obviously a pseudocyst then don’t need EUS • EUS +/- FNA is indicated to further assess and categorize cystic pancreatic lesions World J Surg (2008) 32:2028–2037

  7. EUS Morphology • Cyst wall • Thick vs. thin • Solid component • Associated with malignancy • Septations • Micro vs. macrocystic • Ductal abnormalities • Main duct vs. side duct • Number of cyst • Lymphadenopathy • EUS morphology can correctly differentiate mucinous from non-mucinous cystic lesions approximately 50% of the time JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  8. Normal Pancreas—EUS image of the normal pancreas (P, outlined by short arrows) with a finely granular echoic pattern that is characteristically very homogeneous. A part of the normal diameter (1 mm) pancreatic duct (pd) is seen in the tail. Upper pole of the kidney (K) is also visible. (Magnification range scale = 9 cm).

  9. JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  10. Examples of Morphology JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  11. JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  12. JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  13. JOP. J Pancreas (Online) 2010 Jul 5; 11(4):299-309.

  14. FNA & Fluid Analysis • Cytology • High specificity, low sensitivity • Mucin • High specificity, low sensitivity • Amylase/Lipase • Elevated in Pseudocyst & IPMNs • Low in SCN & MCN • CEA • Most accurate test to distinguish mucinous from non-mucinous cyst • DNA analysis • Mixed data when compared to CEA

  15. World J Surg (2008) 32:2028–2037

  16. Cyst Fluid Analysis ASGE Guidelines 2005

  17. Application A retrospective analysis of 153 pts undergoing EUS for pancreatic cyst between 1996 to 2007 Clinical history, EUS characteristics, cytology, tumor markers and surgical histology were collected Predictors of malignancy were determined by univariate and multivariate analysis Aliment Pharmacol Ther. 2010 Jan 15;31(2):285-94

  18. Application Prospective study of 341 pts found to have a pancreatic cystic lesion >10 mm on abd imaging Exclusion criteria included: abnormal coags/platelets &/or an abscess EUS was performed looking at morphology, cyst fluid cytology, and cyst fluid tumor markers (CEA, CA 72-4, CA 125, CA 19-9, and CA 15-3) Gastroenterology. 2004 May;126(5):1330-6

  19. Gastroenterology. 2004 May;126(5):1330-6

  20. Summary • No single test or imaging modality can reliably differentiate cyst type • Composite data is needed • Clinical features of the patient • Cross-sectional imaging • Tumor markers • EUS with cyst fluid analysis

  21. http://daveproject.org/pancreas-chronic-pancreatitis-with-eus-fna-of-pseudocyst/2004-05-07/http://daveproject.org/pancreas-chronic-pancreatitis-with-eus-fna-of-pseudocyst/2004-05-07/ http://daveproject.org/pancreas-eusfna-of-ipmn-with-malignant-transformation/2007-11-13/ ASGE Guidelines 2005

  22. http://daveproject.org/pancreas-serous-cyst-with-bleeding/2009-04-23/http://daveproject.org/pancreas-serous-cyst-with-bleeding/2009-04-23/ http://daveproject.org/pancreas-serous-cystadenoma-with-fna/2007-11-13/ http://daveproject.org/eus-fna-of-solid-pseudopapillary-tumor/2011-02-21/ ASGE Guidelines 2005

  23. GASTROENTEROLOGY 2005;128:463–469

More Related